IgA nephropathy: open trials in South Korea

10 open trials have a site in South Korea. Registry data; only the trial team decides who can take part.

NCT06963827
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Trial Treatment · Phase 3 · Takeda
Seoul National University Bundang Hospital, Seongnam-si · Seoul National University Hospital, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Seoul National University Boramae Medical Center, Seoul · Ajou University Hospital-Primary Research Location, Suwon · Yongin Severance Hospital, Yonsei University Health System, Yongin-si
Registry updated 2026-11-04
NCT07541287
A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
Trial Treatment · Phase 2 · Jade Biosciences, Inc.
Anyang-si · Seongnam-si · Seoul · Suwon
Registry updated 2026-10-30
NCT07146906
A Study to Assess the Effects of Zigakibart on IgA Nephropathy.
Trial Treatment · Phase 2 · Novartis Pharmaceuticals
Seoul
Registry updated 2026-10-21
NCT06989359
Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
Trial Treatment · Phase 2 · ADARx Pharmaceuticals, Inc.
Cheonan · Daegu · Gyeonggi-do · Seoul · Wŏnju
Registry updated 2026-10-20
NCT07498335
Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Seoul
Registry updated 2026-10-15
NCT06935357
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
Trial Treatment · Phase 3 · Biogen
Hallym University Sacred Heart Hospital, Anyang-si · Pusan National University Hospital, Busan · Inje University Haeundae Paik Hospital, Busan · Seoul National University Bundang Hospital, Seongnam-si · Severance Hospital, Yonsei University Health System, Seoul · Seoul National University Hospital, Seoul · Hanyang University Seoul Hospital, Seoul · Samsung Medical Center, Seoul · Ajou University Hospital, Suwon
Registry updated 2026-10-14
NCT04557462
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Bundang Gu · Busan · Cheongju-si · Seoul · Taegu
Registry updated 2026-10-05
NCT06858319
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Cheonan · Guri-si · Seongnam-si · Seoul
Registry updated 2026-08-17
NCT07024563
Study of Ravulizumab in Pediatric Participants With Primary IgAN
Trial Treatment · Phase 3 · Alexion Pharmaceuticals, Inc.
Seoul
Registry updated 2026-07-30
NCT03929887
KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis
Research · Seoul National University Hospital
Kangwon National University Hospital, Chuncheon · Keimyung University - Dongsan Medical Center, Daegu · SMG-SNU Boramae Medical Center, Seoul · Chung-Ang University Hosptial, Seoul · Seoul National University Hospital, Seoul · Severance hospital, Seoul
Registry updated 2020-02-12

All IgA nephropathy trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error